Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Non-metastatic castration-resistant prostate cancer, Metastatic hormone-sensitive prostate cancer, Androgen deprivation & AR pathway inhibitors, PSMA PET and the tag subtype-page.
Shares PET (positron emission tomography), Etoposide, Cisplatin, Carboplatin and the tag subtype-page.
Shares Metastatic hormone-sensitive prostate cancer, Androgen deprivation & AR pathway inhibitors, PSMA PET, Prostate cancer and the tag subtype-page.
Shares TP53, Carboplatin, Pembrolizumab and the tag subtype-page.
Shares TP53, Carboplatin, Pembrolizumab and the tag subtype-page.
Shares Carboplatin, Pembrolizumab and the tag subtype-page.
Shares Cisplatin, Carboplatin, Pembrolizumab and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.